# Developing Medical Imaging Drug and Biological Products Part 2: Clinical Indications - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/developing-medical-imaging-drug-and-biological-products-part-2-clinical-indications/b799f895-2a25-481d-85aa-d8b5f1322a85

> FDA guidance document: Developing Medical Imaging Drug and Biological Products Part 2: Clinical Indications. Issue date: June 22, 2004. Get complete insights and analysis.

---

## Details

- Title: Developing Medical Imaging Drug and Biological Products Part 2: Clinical Indications
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2004-06-22
- Last Changed: 2020-04-28
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1998-D-0035">FDA-1998-D-0035</a>

## Related Documents

- [Developing Medical Imaging Drug and Biological Products Part 1: Conducting Safety Assessments](https://www.globalkeysolutions.net/guidances/guidance-document/developing-medical-imaging-drug-and-biological-products-part-1-conducting-safety-assessments/7bd6bcd1-17d8-43a5-90f7-417b39f3ebf4)
- [Possible Dioxin/PCB Contamination of Drug and Biological Products](https://www.globalkeysolutions.net/guidances/guidance-document/possible-dioxinpcb-contamination-of-drug-and-biological-products/0b7513ce-1394-47e9-950d-c555f4b6845a)
- [Developing Medical Imaging Drug and Biological Products Part 3: Design, Analysis, and Interpretation of Clinical Studies](https://www.globalkeysolutions.net/guidances/guidance-document/developing-medical-imaging-drug-and-biological-products-part-3-design-analysis-and-interpretation-of-clinical-studies/560bad6d-d575-4a09-84e7-a396f541a476)